Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.

To determine the etiology of community-acquired pneumonia in the adult population of a defined area, specific antibody responses in paired serum samples, levels of circulating pneumococcal immune complexes in serum samples, and pneumococcal antigen in urine were measured. Samples (304 paired serum samples and 300 acute urine samples) were obtained from 345 patients > or =15 years old with community-acquired, radiologically confirmed pneumonia, which comprised all cases in the population of 4 municipalities in eastern Finland during 1 year. Specific infecting organisms were identified in 183 patients (including 49 with mixed infection), as follows: Streptococcus pneumoniae, 125 patients; Haemophilus influenzae, 12; Moraxella catarrhalis, 8; chlamydiae, 37 (of which, Chlamydia pneumoniae, 30); Mycoplasma pneumoniae, 30; and virus species, 27. The proportion of patients with pneumococcal infections increased and of those with Mycoplasma infections decreased with age, but for each age group, the etiologic profile was similar among inpatients and among outpatients. S. pneumoniae was the most important etiologic agent. The annual incidence of pneumococcal pneumonia per 1000 inhabitants aged > or =60 years was 8.0.

[1]  M. Leinonen,et al.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. , 1999, Vaccine.

[2]  I. Bolíbar,et al.  Risk factors for community-acquired pneumonia in adults: a population-based case-control study. , 1999, The European respiratory journal.

[3]  M. Leinonen,et al.  Etiology of childhood pneumonia: serologic results of a prospective, population-based study. , 1998, The Pediatric infectious disease journal.

[4]  M. Leinonen,et al.  Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Leinonen,et al.  Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. , 1997, The American journal of medicine.

[6]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[7]  S. Norrby.  Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. , 1997 .

[8]  L. Brammer,et al.  Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[9]  S. Ragnar Norrby.  Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. , 1997, The Journal of antimicrobial chemotherapy.

[10]  J. P. Davis,et al.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[12]  E. Manor,et al.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.

[13]  M. Leinonen,et al.  Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. , 1996, The Journal of infectious diseases.

[14]  J. Bartlett,et al.  Community‐Acquired Pneumonia: Impact of Immune Status , 1996, American journal of respiratory and critical care medicine.

[15]  M. Leinonen,et al.  The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. , 1995, The Journal of infectious diseases.

[16]  C. Pugliese,et al.  Community-acquired pneumonia: is there difference in etiology between hospitalized and out-patients? , 1995, Minerva medica.

[17]  L. Bakaletz,et al.  Viral potentiation of bacterial superinfection of the respiratory tract. , 1995, Trends in microbiology.

[18]  A. Verghese,et al.  New pathogens in pneumonia. , 1994, The Medical clinics of North America.

[19]  M. Leinonen,et al.  Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. , 1994, The Journal of infectious diseases.

[20]  M. Leinonen,et al.  Moraxella catarrhalis--an uncommon cause of community-acquired pneumonia in Swedish children. , 1994, Scandinavian journal of infectious diseases.

[21]  W. Boersma,et al.  Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay , 1993, Journal of clinical microbiology.

[22]  S. Soimakallio,et al.  Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. , 1993, American journal of epidemiology.

[23]  D. Barnes.  Microbial etiology of acute pneumonia in hospitalized patients. , 1993, Chest.

[24]  P. Saikku,et al.  The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987 , 1993, Epidemiology and Infection.

[25]  P. Coll,et al.  Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. , 1993, The European respiratory journal.

[26]  J. Bates,et al.  Microbial etiology of acute pneumonia in hospitalized patients. , 1992, Chest.

[27]  J. Blanquer,et al.  Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. , 1991, Thorax.

[28]  M. Leinonen,et al.  Pneumolysin, produced in Bacillus subtilis as antigen in enzyme immunoassay for etiological diagnosis of pneumococcal pneumonia , 1990 .

[29]  M. Leinonen.  Demonstration of pneumolysin antibodies in circulating immune complexes - a new diagnoxtic method for pneumococcal pneumonia. , 1990 .

[30]  M. Leinonen,et al.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. , 1990, The European respiratory journal.

[31]  W. Kapoor,et al.  New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.

[32]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[33]  L. Campbell,et al.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. , 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[34]  J. Macfarlane,et al.  PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY , 1987, The Lancet.

[35]  M. Leinonen,et al.  The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. , 1987, The Journal of infection.

[36]  M. Leinonen,et al.  Chlamydial pneumonitis and its serodiagnosis in infants. , 1984, The Journal of infectious diseases.

[37]  M. Leinonen,et al.  The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. , 1983, Science.

[38]  M. Skeet.  Protecting the health of the elderly : a review of WHO activities , 1983 .

[39]  J. Macfarlane,et al.  HOSPITAL STUDY OF ADULT COMMUNITY-ACQUIRED PNEUMONIA , 1982, The Lancet.

[40]  M. Leinonen,et al.  Serum antibody response to pneumococcal otitis media. , 1982, Pediatric infectious disease.

[41]  M. Leinonen,et al.  Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. , 1981, The Journal of infectious diseases.

[42]  F. R. Woolley,et al.  A cost-benefit analysis of immunization for pneumococcal pneumonia. , 1981, JAMA.

[43]  J. Lumio,et al.  Q fever in Finland: clinical, immunological and epidemiological findings. , 1981, Scandinavian journal of infectious diseases.

[44]  M. Leinonen,et al.  Detection of Pneumococcal Capsular polysaccharide antigens by latex agglutination, counterimmunoelectrophoresis, and radioimmunoassay in middle ear exudates in acute otitis media , 1980, Journal of clinical microbiology.

[45]  R. Pyhälä,et al.  The value of complement fixation and haemagglutination inhibition tests in the diagnosis of influenza A. , 1976, Acta virologica.

[46]  G. Kenny,et al.  Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. , 1975, The American review of respiratory disease.

[47]  M. Cooney,et al.  Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period. , 1973, American journal of epidemiology.

[48]  W. Dowdle,et al.  Adult pneumonia in a general hospital. Etiology and host risk factors. , 1972, Archives of internal medicine.

[49]  Solov'ev Vd.  [Laboratory diagnosis of influenza]. , 1951, Sovetskaia meditsina.

[50]  A. J. Rhodes.  The Laboratory Diagnosis of Influenza , 1946, Edinburgh medical journal.